Cargando…
Circulating CD45(+)EpCAM(+) cells as a diagnostic marker for early-stage primary lung cancer
Lung cancer is a highly prevalent type of cancer, accounting for 11.6% of all cancer incidences. Early detection and treatment can significantly improve the survival rate and quality of life of patients; however, there is no accurate, effective, and easy-to-use test for early lung cancer screening....
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487715/ https://www.ncbi.nlm.nih.gov/pubmed/36147748 http://dx.doi.org/10.3389/fmedt.2022.982308 |